<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8" />
<title>ControlType xref</title>
<link type="text/css" rel="stylesheet" href="../../../../../stylesheet.css" />
</head>
<body>
<div id="overview"><a href="../../../../../../apidocs/org/biopax/paxtools/model/level3/ControlType.html">View Javadoc</a></div><pre>
<a class="jxr_linenumber" name="L1" href="#L1">1</a>   <strong class="jxr_keyword">package</strong> org.biopax.paxtools.model.level3;
<a class="jxr_linenumber" name="L2" href="#L2">2</a>   
<a class="jxr_linenumber" name="L3" href="#L3">3</a>   
<a class="jxr_linenumber" name="L4" href="#L4">4</a>   <em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L5" href="#L5">5</a>   <em class="jxr_javadoccomment"> * Defines the nature of the control relationship between the controller and the controlled entities.</em>
<a class="jxr_linenumber" name="L6" href="#L6">6</a>   <em class="jxr_javadoccomment">*/</em>
<a class="jxr_linenumber" name="L7" href="#L7">7</a>   <strong class="jxr_keyword">public</strong> enum <a name="ControlType" href="../../../../../org/biopax/paxtools/model/level3/ControlType.html#ControlType">ControlType</a>
<a class="jxr_linenumber" name="L8" href="#L8">8</a>   {
<a class="jxr_linenumber" name="L9" href="#L9">9</a>   	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L10" href="#L10">10</a>  <em class="jxr_javadoccomment">	 * General activation. Compounds that activate the specified enzyme activity by an unknown mechanism. The</em>
<a class="jxr_linenumber" name="L11" href="#L11">11</a>  <em class="jxr_javadoccomment">	 * mechanism is defined as unknown, because either the mechanism has yet to be elucidated in the experimental</em>
<a class="jxr_linenumber" name="L12" href="#L12">12</a>  <em class="jxr_javadoccomment">	 * literature, or the paper(s) curated thus far do not define the mechanism, and a full literature search has</em>
<a class="jxr_linenumber" name="L13" href="#L13">13</a>  <em class="jxr_javadoccomment">	 * yet to be performed.</em>
<a class="jxr_linenumber" name="L14" href="#L14">14</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L15" href="#L15">15</a>  	ACTIVATION,
<a class="jxr_linenumber" name="L16" href="#L16">16</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L17" href="#L17">17</a>  <em class="jxr_javadoccomment">	 * General inhibition. Compounds that inhibit the specified enzyme activity by an unknown mechanism. The</em>
<a class="jxr_linenumber" name="L18" href="#L18">18</a>  <em class="jxr_javadoccomment">	 * mechanism is defined as unknown, because either the mechanism has yet to be elucidated in the experimental</em>
<a class="jxr_linenumber" name="L19" href="#L19">19</a>  <em class="jxr_javadoccomment">	 * literature, or the paper(s) curated thus far do not define the mechanism, and a full literature search has</em>
<a class="jxr_linenumber" name="L20" href="#L20">20</a>  <em class="jxr_javadoccomment">	 * yet to be performed.</em>
<a class="jxr_linenumber" name="L21" href="#L21">21</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L22" href="#L22">22</a>  	INHIBITION,
<a class="jxr_linenumber" name="L23" href="#L23">23</a>  
<a class="jxr_linenumber" name="L24" href="#L24">24</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L25" href="#L25">25</a>  <em class="jxr_javadoccomment">	 * @deprecated LEVEL 1 workaround</em>
<a class="jxr_linenumber" name="L26" href="#L26">26</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L27" href="#L27">27</a>  	ACTIVATION_UNKMECH,
<a class="jxr_linenumber" name="L28" href="#L28">28</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L29" href="#L29">29</a>  <em class="jxr_javadoccomment">	 * @deprecated LEVEL 1 workaround</em>
<a class="jxr_linenumber" name="L30" href="#L30">30</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L31" href="#L31">31</a>  	INHIBITION_UNKMECH,
<a class="jxr_linenumber" name="L32" href="#L32">32</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L33" href="#L33">33</a>  <em class="jxr_javadoccomment">	 * Allosteric inhibitors decrease the specified enzyme activity by binding reversibly to the enzyme and</em>
<a class="jxr_linenumber" name="L34" href="#L34">34</a>  <em class="jxr_javadoccomment">	 * inducing a conformational change that decreases the affinity of the enzyme to its substrates without</em>
<a class="jxr_linenumber" name="L35" href="#L35">35</a>  <em class="jxr_javadoccomment">	 * affecting its VMAX. Allosteric inhibitors can be competitive or noncompetitive inhibitors, therefore,</em>
<a class="jxr_linenumber" name="L36" href="#L36">36</a>  <em class="jxr_javadoccomment">	 * those inhibition categories can be used in conjunction with this category.</em>
<a class="jxr_linenumber" name="L37" href="#L37">37</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L38" href="#L38">38</a>  	INHIBITION_ALLOSTERIC,
<a class="jxr_linenumber" name="L39" href="#L39">39</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L40" href="#L40">40</a>  <em class="jxr_javadoccomment">	 * Competitive inhibitors are compounds that competitively inhibit the specified enzyme activity by binding</em>
<a class="jxr_linenumber" name="L41" href="#L41">41</a>  <em class="jxr_javadoccomment">	 * reversibly to the enzyme and preventing the substrate from binding. Binding of the inhibitor and substrate</em>
<a class="jxr_linenumber" name="L42" href="#L42">42</a>  <em class="jxr_javadoccomment">	 * are mutually exclusive because it is assumed that the inhibitor and substrate can both bind only to the free</em>
<a class="jxr_linenumber" name="L43" href="#L43">43</a>  <em class="jxr_javadoccomment">	 * enzyme. A competitive inhibitor can either bind to the active site of the enzyme,</em>
<a class="jxr_linenumber" name="L44" href="#L44">44</a>  <em class="jxr_javadoccomment">	 * directly excluding the substrate from binding there, or it can bind to another site on the enzyme,</em>
<a class="jxr_linenumber" name="L45" href="#L45">45</a>  <em class="jxr_javadoccomment">	 * altering the conformation of the enzyme such that the substrate can not bind to the active site.</em>
<a class="jxr_linenumber" name="L46" href="#L46">46</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L47" href="#L47">47</a>  	INHIBITION_COMPETITIVE,
<a class="jxr_linenumber" name="L48" href="#L48">48</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L49" href="#L49">49</a>  <em class="jxr_javadoccomment">	 * Irreversible inhibitors are compounds that irreversibly inhibit the specified enzyme activity by binding to</em>
<a class="jxr_linenumber" name="L50" href="#L50">50</a>  <em class="jxr_javadoccomment">	 * the enzyme and dissociating so slowly that it is considered irreversible. For example, alkylating agents,</em>
<a class="jxr_linenumber" name="L51" href="#L51">51</a>  <em class="jxr_javadoccomment">	 * such as iodoacetamide, irreversibly inhibit the catalytic activity of some enzymes by modifying cysteine</em>
<a class="jxr_linenumber" name="L52" href="#L52">52</a>  <em class="jxr_javadoccomment">	 * side chains.</em>
<a class="jxr_linenumber" name="L53" href="#L53">53</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L54" href="#L54">54</a>  	INHIBITION_IRREVERSIBLE,
<a class="jxr_linenumber" name="L55" href="#L55">55</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L56" href="#L56">56</a>  <em class="jxr_javadoccomment">	 * Noncompetitive inhibitors are compounds that noncompetitively inhibit the specified enzyme by binding</em>
<a class="jxr_linenumber" name="L57" href="#L57">57</a>  <em class="jxr_javadoccomment">	 * reversibly to both the free enzyme and to the enzyme-substrate complex. The inhibitor and substrate may be</em>
<a class="jxr_linenumber" name="L58" href="#L58">58</a>  <em class="jxr_javadoccomment">	 * bound to the enzyme simultaneously and do not exclude each other. However, only the enzyme-substrate complex</em>
<a class="jxr_linenumber" name="L59" href="#L59">59</a>  <em class="jxr_javadoccomment">	 * (not the enzyme-substrate-inhibitor complex) is catalytically active.</em>
<a class="jxr_linenumber" name="L60" href="#L60">60</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L61" href="#L61">61</a>  	INHIBITION_NONCOMPETITIVE,
<a class="jxr_linenumber" name="L62" href="#L62">62</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L63" href="#L63">63</a>  <em class="jxr_javadoccomment">	 * Compounds that inhibit the specified enzyme activity by a mechanism that has been characterized,</em>
<a class="jxr_linenumber" name="L64" href="#L64">64</a>  <em class="jxr_javadoccomment">	 * but that cannot be clearly classified as irreversible, competitive, noncompetitive, uncompetitive,</em>
<a class="jxr_linenumber" name="L65" href="#L65">65</a>  <em class="jxr_javadoccomment">	 * or allosteric.</em>
<a class="jxr_linenumber" name="L66" href="#L66">66</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L67" href="#L67">67</a>  	INHIBITION_OTHER,
<a class="jxr_linenumber" name="L68" href="#L68">68</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L69" href="#L69">69</a>  <em class="jxr_javadoccomment">	 * Uncompetitive inhibitors are compounds that uncompetitively inhibit the specified enzyme activity by binding</em>
<a class="jxr_linenumber" name="L70" href="#L70">70</a>  <em class="jxr_javadoccomment">	 * reversibly to the enzyme-substrate complex but not to the enzyme alone.</em>
<a class="jxr_linenumber" name="L71" href="#L71">71</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L72" href="#L72">72</a>  	INHIBITION_UNCOMPETITIVE,
<a class="jxr_linenumber" name="L73" href="#L73">73</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L74" href="#L74">74</a>  <em class="jxr_javadoccomment">	 * Nonallosteric activators increase the specified enzyme activity by means other than allosteric.</em>
<a class="jxr_linenumber" name="L75" href="#L75">75</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L76" href="#L76">76</a>  	ACTIVATION_NONALLOSTERIC,
<a class="jxr_linenumber" name="L77" href="#L77">77</a>  	<em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L78" href="#L78">78</a>  <em class="jxr_javadoccomment">	 * Allosteric activators increase the specified enzyme activity by binding reversibly to the enzyme and</em>
<a class="jxr_linenumber" name="L79" href="#L79">79</a>  <em class="jxr_javadoccomment">	 * inducing a conformational change that increases the affinity of the enzyme to its substrates without</em>
<a class="jxr_linenumber" name="L80" href="#L80">80</a>  <em class="jxr_javadoccomment">	 * affecting its VMAX.</em>
<a class="jxr_linenumber" name="L81" href="#L81">81</a>  <em class="jxr_javadoccomment">	 */</em>
<a class="jxr_linenumber" name="L82" href="#L82">82</a>  	ACTIVATION_ALLOSTERIC
<a class="jxr_linenumber" name="L83" href="#L83">83</a>  }
</pre>
<hr/>
<div id="footer">Copyright &#169; 2023 <a href="http://www.biopax.org">BioPAX</a>. All rights reserved.</div>
</body>
</html>
